REQUEST A DEMO
Total
USD $0.00
Search more companies

Athenex Cidal Ecuador Athenexecua S.A. (Ecuador)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Full name: Athenex Cidal Ecuador Athenexecua S.A. Profile Updated: June 27, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Athenex Cidal Ecuador Athenexecua S.A. is a company based in Ecuador, with its head office in Quito. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. Athenex Cidal Ecuador Athenexecua S.A. was incorporated on September 23, 2019. 1 (2022) employees currently work for Athenex Cidal Ecuador Athenexecua S.A.. From the latest financial highlights, Athenex Cidal Ecuador Athenexecua S.A. reported a net sales revenue drop of 49.68% in 2022. Its’ total assets recorded a growth of 43.4%. The enterprise’s net profit margin decreased by 6.75% in 2022.

Headquarters
Av. Republica del Salvador N36-230
Quito; Pichincha;

Contact Details: Purchase the Athenex Cidal Ecuador Athenexecua S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Athenex Cidal Ecuador Athenexecua S.A. report to view the information.
Outstanding Shares:
Purchase the Athenex Cidal Ecuador Athenexecua S.A. report to view the information.
Registered Capital:
Purchase the Athenex Cidal Ecuador Athenexecua S.A. report to view the information.
Incorporation Date:
September 23, 2019
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.88%
Purchase this report to view the information.
0.12%
Company Performance
Financial values in the chart are available after Athenex Cidal Ecuador Athenexecua S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-49.68%
Total operating revenue
-49.78%
Operating profit (EBIT)
-90.92%
Net Profit (Loss) for the Period
-97.89%
Total assets
43.4%
Total equity
N/A
Operating Profit Margin (ROS)
-8.95%
Net Profit Margin
-6.75%
Return on Equity (ROE)
N/A
Quick Ratio
1.03%
Cash Ratio
1.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?